Caribou Biosciences Inc (CRBU): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,857 US Dollar | 6 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 107.207.513 | 12,57 | 11,14 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Caribou Biosciences Inc
Mitarbeiter 97
Handelsplatz NASDAQ
Ticker Symbol CRBU
IPO Datum 2021-07-23
Adresse 2929 7th Street, Berkeley, CA, United States, 94710
Webseite https://cariboubio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Rachel E. Haurwitz Ph.D. | Co-Founder, CEO, President & Director |
| 2 | Mr. Sriram Ryali M.B.A. | Chief Financial Officer |
| 3 | Ms. Barbara G. McClung Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| 4 | Dr. Jennifer A. Doudna Ph.D. | Co-founder & Member of Scientific Advisory Board |
| 5 | Mr. Ryan Fischesser | Interim Principal Accounting Officer & Controller |
| 6 | Dr. Justin Skoble Ph.D. | Senior Vice President of Technical Operations |
| 7 | Ms. Reigin Zawadzki | Chief People Officer |
| 8 | Dr. Tina Albertson M.D., Ph.D. | Chief Medical Officer |
| 9 | Mr. Enrique Zudaire Ph.D. | Senior Vice President of Translational Research |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 7,29% | 9,54 Mio. USD |
| 2 | Pfizer Inc | 4,38% | 5,72 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 3,93% | 5,13 Mio. USD |
| 4 | Mackenzie Investments | 3,41% | 4,45 Mio. USD |
| 5 | Renaissance Technologies Corp | 2,59% | 3,38 Mio. USD |
| 6 | Kynam Capital Management, LP | 2,34% | 3,05 Mio. USD |
| 7 | Geode Capital Management, LLC | 2,22% | 2,90 Mio. USD |
| 8 | Acadian Asset Management LLC | 1,66% | 2,17 Mio. USD |
| 9 | State Street Corp | 1,52% | 1,99 Mio. USD |
| 10 | Bank of America Corp | 1,32% | 1,72 Mio. USD |
| 11 | Two Sigma Investments LLC | 0,98% | 1,28 Mio. USD |
| 12 | Dimensional Fund Advisors, Inc. | 0,91% | 1,19 Mio. USD |
| 13 | Charles Schwab Investment Management Inc | 0,72% | 0,95 Mio. USD |
| 14 | CAMBRIDGE Invest RESEARCH ADVISORS, INC. | 0,71% | 0,93 Mio. USD |
| 15 | FMR Inc | 0,68% | 0,89 Mio. USD |
| 16 | Northern Trust Corp | 0,67% | 0,87 Mio. USD |
| 17 | Maverick Capital Ltd | 0,61% | 0,80 Mio. USD |
| 18 | Vanguard Portfolio Management, LLC | 0,57% | 0,75 Mio. USD |
| 19 | Vanguard Fiduciary Trust Co | 0,57% | 0,74 Mio. USD |
| 20 | Qube Research & Technologies | 0,51% | 0,67 Mio. USD |